{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:22:07Z","timestamp":1740147727438,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s11739-023-03448-9","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T16:01:44Z","timestamp":1697558504000},"page":"5-7","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A balloon is better than diet: the role of lifestyle changes in the management of obesity and steatotic liver, and need for a winning strategy"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5476-7376","authenticated-orcid":false,"given":"Agostino","family":"Di Ciaula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Portincasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"key":"3448_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L (2023) The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77:1335\u20131347","journal-title":"Hepatology"},{"key":"3448_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00800-4","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Zelber-Sagi S, Henry L, Gerber LH (2023) Lifestyle interventions in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. https:\/\/doi.org\/10.1038\/s41575-023-00800-4","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3448_CR3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","volume":"55","author":"J Ludwig","year":"1980","unstructured":"Ludwig J, Viggiano TR, McGill DB, Oh BJ (1980) Nonalcoholic steatohepatitis: mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55:434\u2013438","journal-title":"Mayo Clin Proc"},{"key":"3448_CR4","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s11739-023-03203-0","volume":"18","author":"P Portincasa","year":"2023","unstructured":"Portincasa P (2023) NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care. Intern Emerg Med 18:993\u20131006","journal-title":"Intern Emerg Med"},{"key":"3448_CR5","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S2468-1253(22)00062-0","volume":"7","author":"N Mendez-Sanchez","year":"2022","unstructured":"Mendez-Sanchez N, Bugianesi E, Gish RG, Lammert F, Tilg H, Nguyen MH et al (2022) Global multi-stakeholder endorsement of the MAFLD definition. Lancet Gastroenterol Hepatol 7:388\u2013390","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3448_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F et al (2023) A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. https:\/\/doi.org\/10.1097\/HEP.0000000000000520","journal-title":"Hepatology"},{"key":"3448_CR7","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1111\/liv.14675","volume":"40","author":"S Yamamura","year":"2020","unstructured":"Yamamura S, Eslam M, Kawaguchi T, Tsutsumi T, Nakano D, Yoshinaga S et al (2020) MAFLD identifies patients with significant hepatic fibrosis better than NAFLD. Liver Int 40:3018\u20133030","journal-title":"Liver Int"},{"key":"3448_CR8","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1007\/s10620-022-07512-w","volume":"67","author":"AR Scheinberg","year":"2022","unstructured":"Scheinberg AR, John BV (2022) MAFLD versus NAFLD: Which better predicts the risk of atherosclerotic cardiovascular disease? Dig Dis Sci 67:4606\u20134608","journal-title":"Dig Dis Sci"},{"key":"3448_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.08.003","author":"Q Zhao","year":"2023","unstructured":"Zhao Q, Deng Y (2023) Comparison of mortality outcomes in individuals with MASLD and\/or MAFLD. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2023.08.003","journal-title":"J Hepatol"},{"key":"3448_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-023-03417-2","author":"A van Dijk","year":"2023","unstructured":"van Dijk A, de Vries M, El-Morabit F, Bac ST, Mundt MW, van der Schuit LE et al (2023) Intra-gastric balloon with lifestyle modification a promising therapeutic option for overweight and obese patients with metabolic dysfunction-associated steatotic liver disease. Intern Emerg Med. https:\/\/doi.org\/10.1007\/s11739-023-03417-2. (in press)","journal-title":"Intern Emerg Med"},{"key":"3448_CR11","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s11695-022-06437-7","volume":"33","author":"RH Shah","year":"2023","unstructured":"Shah RH, Vedantam S, Kumar S, Amin S, Pearlman M, Bhalla S (2023) Intragastric balloon significantly improves metabolic parameters at 6 months: a meta-analysis. Obes Surg 33:725\u2013732","journal-title":"Obes Surg"},{"key":"3448_CR12","doi-asserted-by":"publisher","first-page":"100203","DOI":"10.1016\/j.jhepr.2020.100203","volume":"3","author":"E Molina-Molina","year":"2021","unstructured":"Molina-Molina E, Shanmugam H, Di Ciaula A, Grattagliano I, Di Palo DM, Palmieri VO, Portincasa P (2021) ((13)C)-Methacetin breath test provides evidence of subclinical liver dysfunction linked to fat storage but not lifestyle. JHEP Rep 3:100203","journal-title":"JHEP Rep"},{"key":"3448_CR13","doi-asserted-by":"publisher","first-page":"7212","DOI":"10.1007\/s00464-023-10209-4","volume":"37","author":"D Abbitt","year":"2023","unstructured":"Abbitt D, Netsanet A, Kovar A, Choy K, Jones TS, Cassell B et al (2023) Losing weight to achieve joint or hernia surgery: is the intragastric balloon the answer? Surg Endosc 37:7212\u20137217","journal-title":"Surg Endosc"},{"key":"3448_CR14","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1007\/s11695-023-06716-x","volume":"33","author":"MS Foula","year":"2023","unstructured":"Foula MS, Amer NM, Zakaria H, Ismail MH, Alshomimi SJ, Al Bisher HM et al (2023) Surgical management of intra-gastric balloon complications, single-center experience, and literature review. Obes Surg 33:2718\u20132724","journal-title":"Obes Surg"},{"key":"3448_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000524895","volume":"16","author":"M Oster","year":"2023","unstructured":"Oster M, Hein N, Aksan A, Krammer H, Theodoridou S, Stein J (2023) Efficacy and safety of intragastric balloon therapy compared to a multidisciplinary weight loss program (OPTIFAST) in a real-world population: a propensity score matching analysis. Obes Facts 16:89\u201398","journal-title":"Obes Facts"},{"key":"3448_CR16","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S2213-8587(19)30093-2","volume":"7","author":"Q Gong","year":"2019","unstructured":"Gong Q, Zhang P, Wang J, Ma J, An Y, Chen Y et al (2019) Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing diabetes prevention outcome study. Lancet Diabetes Endocrinol 7:452\u2013461","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3448_CR17","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1002\/hep.32235","volume":"75","author":"ER Kim","year":"2022","unstructured":"Kim ER, Park JS, Kim JH, Oh JY, Oh IJ, Choi DH et al (2022) A GLP-1\/GLP-2 receptor dual agonist to treat NASH: targeting the gut-liver axis and microbiome. Hepatology 75:1523\u20131538","journal-title":"Hepatology"},{"key":"3448_CR18","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/S0140-6736(21)01751-7","volume":"398","author":"DCW Lau","year":"2021","unstructured":"Lau DCW, Erichsen L, Francisco AM, Satylganova A, le Roux CW, McGowan B et al (2021) Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. Lancet 398:2160\u20132172","journal-title":"Lancet"},{"key":"3448_CR19","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1056\/NEJMoa2301972","volume":"389","author":"AM Jastreboff","year":"2023","unstructured":"Jastreboff AM, Kaplan LM, Frias JP, Wu Q, Du Y, Gurbuz S et al (2023) Triple-hormone-receptor agonist retatrutide for obesity-a phase 2 trial. N Engl J Med 389:514\u2013526","journal-title":"N Engl J Med"},{"issue":"5","key":"3448_CR20","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s11154-023-09798-1","volume":"24","author":"A Di Ciaula","year":"2023","unstructured":"Di Ciaula A, Bonfrate L, Khalil M, Garruti G, Portincasa P (2023) Contribution of the microbiome for better phenotyping of people living with obesity. Rev Endocr Metab Disord 24(5):839\u2013870","journal-title":"Rev Endocr Metab Disord"},{"key":"3448_CR21","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.2174\/0929867324666170518095736","volume":"26","author":"A Di Ciaula","year":"2019","unstructured":"Di Ciaula A, Portincasa P (2019) Diet and contaminants: driving the rise to obesity epidemics? Curr Med Chem 26:3471\u20133482","journal-title":"Curr Med Chem"},{"key":"3448_CR22","doi-asserted-by":"publisher","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al (2023) A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003","DOI":"10.1016\/j.jhep.2023.06.003"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-023-03448-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-023-03448-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-023-03448-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:14:39Z","timestamp":1730333679000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-023-03448-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["3448"],"URL":"https:\/\/doi.org\/10.1007\/s11739-023-03448-9","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"type":"print","value":"1828-0447"},{"type":"electronic","value":"1970-9366"}],"subject":[],"published":{"date-parts":[[2023,10,17]]},"assertion":[{"value":"8 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}